Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 6Unknown 2Terminated 1

Sponsor Class

OTHER 32INDUSTRY 3OTHER_GOV 2NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Breast Neoplasms 13Leukemia, Myeloid, Acute 12Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 8Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Vulvar Neoplasms 3Urinary Bladder Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fatigue 3Depression 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Stress Disorders, Post-Traumatic 2Small Cell Lung Carcinoma 2

Interventions

Imatinib Mesylate 2regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NETWORK × Gastrointestinal Stromal Tumors × Clear all
NCT02365441 2023-07-07

ALT GIST

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
78 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00685828 2014-07-04

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
946 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡